Last update 30 Mar 2025

Bevacizumab biosimilar (Lonn Ryonn Pharma)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
Bevacizumab biosimilar, 重组人源化抗VEGF单抗(深圳龙瑞药业), SYN-050
Target
VEGF-A
Action
inhibitors
Mechanism
VEGF-A inhibitors(Vascular endothelial growth factor A inhibitors), Angiogenesis inhibitors
Therapeutic Areas
Neoplasms
Active Indication
Neoplasms
Inactive Indication-
Originator Organization
Lonn Ryonn PHARMA Ltd.Lonn Ryonn PHARMA Ltd.
Active Organization
Synermore Biologics Co., Ltd.Synermore Biologics Co., Ltd.
Inactive Organization
Lonn Ryonn PHARMA Ltd.Lonn Ryonn PHARMA Ltd.
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Related

100 Clinical Results associated with Bevacizumab biosimilar (Lonn Ryonn Pharma)
Login to view more data
100 Translational Medicine associated with Bevacizumab biosimilar (Lonn Ryonn Pharma)
Login to view more data
100 Patents (Medical) associated with Bevacizumab biosimilar (Lonn Ryonn Pharma)
Login to view more data
100 Deals associated with Bevacizumab biosimilar (Lonn Ryonn Pharma)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
L01XC07
-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPhase 1
China
Synermore Biologics Co., Ltd.Synermore Biologics Co., Ltd.
29 Aug 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free